Cue Biopharma's Seed - II Round

Cue Biopharma raised a round of funding on December 22, 2016. Investors include MDB Capital.

Cue Biopharma (Cue), formerly Imagen Biopharma, is an immunotherapy company developing biologics engineered to selectively communicate with disease-relevant T cells for the treatment of cancer and aut…

Articles about Cue Biopharma's Seed - II Round: